Abstract
Objective
To determine seroprotective titres for diphtheria, pertussis, tetanus and measles in children with nephrotic syndrome who had received essential immunization.
Methods
Children (2–18 years) with steroid sensitive nephrotic syndrome (SSNS) or steroid-resistant nephrotic syndrome (SRNS) who were in disease remission and had received essential childhood immunization were included. Anti-diphtheria, anti-pertussis, anti-tetanus and anti-measles antibody titres were measured.
Results
Seventy-six (40 with SSNS; 36 with SRNS) children with mean (SD) age 7.54 (3.96) years were enrolled. The time elapsed since last vaccination was >5 years in 68.4% patients. The seroprotection rates for diphtheria, tetanus, pertussis, and measles were 86.8%, 93.4%, 31.6% and 77.6% respectively; lower in SRNS subjects compared to SSNS. Robust seroprotection titers (1.0 IU/mL) for diphtheria were seen in 23.8% SSNS and 17.9% SRNS; P=0.04, and for tetanus in 69.3% SSNS and 43.8% of SRNS subjects; P=0.03, respectively.
Conclusions
Children with nephrotic syndrome especially those with SRNS have lower seroprotective titers for diphtheria, tetanus, pertussis and measles, necessitating a booster dose of DPT/DT/Td and MR/MMR.
Similar content being viewed by others
References
Kemper MJ, Altrogge H, Ganeshow R, Wiefel DE. Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol. 2002;17:413–7.
Han JW, Lee KY, Hwang JY, Koh DK, Lee J. Antibody status in children with steroid sensitive nephrotic syndrome. Yonsei Med J. 2010;51:239–43.
Kwon HJ, Lee JW, Chung NG, et al. Assessment of serologic immunity to Diphtheria-Tetanus-Pertussis after treatment of Korean Pediatric hematology and oncology patients. J Korean Med Sci. 2012;27:78–83.
Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Org. 2003;81:61–70.
Mantan M, Pandharikar N, Yadav S, Chakravarti A, Sethi G R. Sero-protection for hepatitis B in children with nephrotic syndrome. Pediatr Nephrol. 2013;28:2125–30.
Indian Pediatric Nephrology Group, Indian Academy of Pediatrics. Management of Steroid Sensitive Nephrotic Syndrome: Revised Guidelines. Indian Pediatr. 2008;45: 203–14.
Indian Pediatric Nephrology Group, Indian Academy of Pediatrics. Management of Steroid Resistant Nephrotic Syndrome: Revised Guidelines. Indian Pediatr. 2009;46:35–47.
Wharton M, Vitek CR. Diphtheria Toxoid. In: Plotkin S, Orenstien W, Offit P, eds. Vaccines. 6th ed. New York. Elsevier Publications; 2013:757–60.
Wassilak SGF, Roper MH, Murphy TV, Orenstein WA, Tetanus Toxoid. In: Plotkin S, Orenstien W, Offit P, eds. Vaccines. 6th ed. Elsevier Publications; 2013:757-60.
Efstratiou A, Maple PAC. Laboratory diagnosis of diphtheria. 1994 World Health Organization copenhagen expanded programme on immunization in the European region. Accessed March 19, 2018. Available from: https://apps.who.int/iris/handle/10665/108108
Edwards KM, Decker MD. Pertussis Vaccine. In: Plotkin S, Orenstien W, Offit P, eds. Vaccines. 6th ed. Elsevier Publications; 2013:471-528.
Strebel PM, Papania MJ, Neal A, Haslsey NA. Measles vaccine. In: Plotkin S, Orenstien W, Offit P, eds. Vaccines. 6th ed. Elsevier Publications; 2013:389-440.
Murhekar M. Epidemiology of diphtheria in India, 1996–2016: Implications for prevention and control. Am J Trop Med Hyg. 2017;97:313–8.
Sangal L, Joshi S, Ananadan S, et al. Resurgence of diphtheria in North Kerala, India, 2016: Laboratory supported case-based surveillance outcomes. Front Public Health. 2017;5:218.
Chitkara AJ, Parikh R, Mihalyi A, Kolhapure S. Hexavalent vaccines in India: Current Status. Indian Pediatr. 2019;56:939–50.
Tetanus and adult diptheria: Operational guidelines. Ministry of Health and Family Welfare, Government of India. Accessed August 14, 2020. Available from: https://nhm.gov.in/New_Updates_2018/NHM_Components/Immunization/Guildelines_for_immunization/Td_vaccine_operational_guidelines.pdf
Heijstek MW, Gageldonk PGM, Berbers GAM, Wulffraat NM. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: A retrospective cross-sectional study. Ann Rheum Dis. 2012;71:948–54.
Neupane N, Krishnamurthy S, Jagadisan B, Dhodapkar R. Hepatitis B Seroprotection in Pediatric Nephrotic Syndrome. Indian Pediatr. 2019;56:659–62.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ethical clearance
Institutional Ethics Committee of Maulana Azad Medical College; No.11/IEC/MAMC/2015/317, dated November 27, 2015.
Contributors
MM, SY, AC: conceptualization; AM, AA: Methodology; AM, MM, AD: software; AA, MM, SY: validation; AM, AD, MM: formal analysis; AA, AC: investigation; MM, AC: resources; AM, MM, AD: data curation, AM, MM, AD: writing — original draft; AA, MM, AD: writing — review & editing; MM: visualization; MM, SY, AC: supervision; MM, AA: project administration. All authors approved the final version of manuscript, and are accountable for all aspects related to the study.
Funding
Intramural grant from Maulana Azad Medical College
Competing interest
None.
Rights and permissions
About this article
Cite this article
MAjay, N., Mantan, M., Dabas, A. et al. Seroprotection for Diphtheria, Pertussis, Tetanus and Measles in Children With Nephrotic Syndrome. Indian Pediatr 58, 233–236 (2021). https://doi.org/10.1007/s13312-021-2161-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-021-2161-2